Hepatitis C Virus NS3 Protease and Helicase Inhibitors from Red Sea Sponge (Amphimedon) Species in Green Synthesized Silver Nanoparticles Assisted by in Silico Modeling and Metabolic Profiling

References

• Zhao T, Sun R, Yu S, et al. Size-controlled preparation of silver nanoparticles by a modified polyol method. COLLOID SURF a PHYSICOCHEM ENG ASP. 2010;366(1–3):197–202. doi:10.1016/j.colsurfa.2010.06.005
   Web of Science ®Google Scholar
• Sun Y, Mayers B, Herricks T, Xia Y. Polyol synthesis of uniform silver nanowires: a plausible growth mechanism and the supporting evidence. Nano Lett. 2003;3(7):955–960. doi:10.1021/nl034312m
   Web of Science ®Google Scholar
• Du W-L, Niu -S-S, Xu Y-L, Xu Z-R, Fan C-L. Antibacterial activity of chitosan tripolyphosphate nanoparticles loaded with various metal ions. Carbohydr. 2009;75(3):385–389. doi:10.1016/j.carbpol.2008.07.039
   Google Scholar
• Sinha S, Pan I, Chanda P, Sen SK. Nanoparticles fabrication using ambient biological resources. J Appl Biosci. 2009;19:1113–1130.
   Google Scholar
• Amin M, Anwar F, Janjua MRSA, Iqbal MA, Rashid U. Green synthesis of silver nanoparticles through reduction with solanum xanthocarpum L. berry extract: characterization, antimicrobial and urease inhibitory activities against helicobacter pylori. Int J Mol Sci. 2012;13(8):9923–9941. doi:10.3390/ijms1308992322949839
   PubMed Web of Science ®Google Scholar
• Pastoriza-Santos I, Liz-Marzán LM. Formation of PVP-protected metal nanoparticles in DMF. Langmuir. 2002;18(7):2888–2894. doi:10.1021/la015578g
   Web of Science ®Google Scholar
• Zou J, Zhang F, Huang J, Chang PR, Su Z, Yu J. Effects of starch nanocrystals on structure and properties of waterborne polyurethane-based composites. Carbohydr. 2011;85(4):824–831. doi:10.1016/j.carbpol.2011.04.006
   Google Scholar
• Mondal AK, Mondal S, Samanta S, Mallick S. Synthesis of ecofriendly silver nanoparticle from plant latex used as an important taxonomic tool for phylogenetic interrelationship advances in bioresearch vol. 2. Synthesis. 2011;31:33.
   Google Scholar
• Sekhar EC, Rao K, Rao KMS, Alisha SB. A simple biosynthesis of silver nanoparticles from syzygium cumini stem bark aqueous extract and their spectrochemical and antimicrobial studies. J Appl Pharm. 2018;8(01):073–079.
   Google Scholar
• Singh M, Kalaivani R, Manikandan S, Sangeetha N, Kumaraguru AK. Facile green synthesis of variable metallic gold nanoparticle using Padina gymnospora, a brown marine macroalga. Appl Nanoscience. 2013;3(2):145–151. doi:10.1007/s13204-012-0115-7
   Web of Science ®Google Scholar
• Haggag EG, Elshamy AM, Rabeh MA, et al. Antiviral potential of green synthesized silver nanoparticles of lampranthus coccineus and malephora lutea. Int J Nanomedicine. 2019;14:6217–6229. doi:10.2147/IJN.S21417131496682
   PubMed Web of Science ®Google Scholar
• El-Nour KMA, Eftaiha A, Al-Warthan A, Ammar RA. Synthesis and applications of silver nanoparticles. Arab J Chem. 2010;3(3):135–140. doi:10.1016/j.arabjc.2010.04.008
   Web of Science ®Google Scholar
• Shady NH, Fouad MA, Ahmed S, et al. A new antitrypanosomal alkaloid from the Red Sea marine sponge Hyrtios sp. J Antibiot (Tokyo). 2018;71(12):1036–1039. doi:10.1038/s41429-018-0092-530181571
   PubMed Web of Science ®Google Scholar
• Srividhya S, Chellaram C. Role of marine life in nanomedicine. Ind J Innov Develop. 2012;1(S8):31–33.
   Google Scholar
• Kulkarni SR, Dikshit M. Indian marine pharmacology: a sneak peek into the ecosystem. Proc Indian Natl Sci Acad B. 2018;84(1):281–300.
   Web of Science ®Google Scholar
• Arya G, Sharma N, Mankamna R, Nimesh S. Antimicrobial silver nanoparticles: future of nanomaterials In: Microbial Nanobionics. Springer 2019;89–119.
   Google Scholar
• El-Gaied HAAA. Antiviral evaluation of secondary metabolites derived from actinomycetes conjugated to silver nanoparticles. CU Theses. 2018.
   Google Scholar
• Ryoo S-R, Jang H, Kim K-S, et al. Functional delivery of DNAzyme with iron oxide nanoparticles for hepatitis C virus gene knockdown. Biomaterials. 2012;33(9):2754–2761. doi:10.1016/j.biomaterials.2011.12.01522206595
   PubMed Web of Science ®Google Scholar
• Schiering N, D’Arcy A, Villard F, et al. A macrocyclic HCV NS3/4A protease inhibitor interacts with protease and helicase residues in the complex with its full-length target. PNAS. 2011;108(52):21052–21056. doi:10.1073/pnas.111053410822160684
   PubMed Web of Science ®Google Scholar
• Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345(1):41–52. doi:10.1056/NEJM20010705345010711439948
   PubMed Web of Science ®Google Scholar
• Chlibek R, Smetana J, Sosovickova R, et al. Prevalence of hepatitis C virus in adult population in the Czech Republic - time for birth cohort screening. PLoS One. 2017;12(4):e0175525–e0175525. doi:10.1371/journal.pone.017552528406947
   PubMed Web of Science ®Google Scholar
• Licata A, Minissale MG, Montalto FA, Soresi M. Is vitamin D deficiency predictor of complications development in patients with HCV-related cirrhosis? Intern Emerg Med. 2019;14(5):735–737. doi:10.1007/s11739-019-02072-w30879232
   PubMed Web of Science ®Google Scholar
• Gaballah AM, Esawy MM. Comparison of 2 different antibody assay methods, Elecsys Anti-HCVII (Roche) and Vidas Anti-HCV (Biomerieux), for the detection of antibody to hepatitis C virus in Egypt. Diagn Microbiol Infect Dis. 2018;92(2):107–111. doi:10.1016/j.diagmicrobio.2018.05.01329925467
   PubMed Web of Science ®Google Scholar
• Fujimoto Y, Salam KA, Furuta A, et al. Inhibition of both protease and helicase activities of hepatitis C virus NS3 by an ethyl acetate extract of marine sponge Amphimedon sp. PLoS One. 2012;7(11):e48685. doi:10.1371/journal.pone.004868523144928
   PubMed Web of Science ®Google Scholar
• Moriishi K, Matsuura Y. Exploitation of lipid components by viral and host proteins for hepatitis C virus infection. Front Microbiol. 2012;3:54. doi:10.3389/fmicb.2012.0005422347882
   PubMed Web of Science ®Google Scholar
• Hong TT, Dat TTH, Cuc NTK, Cuong PV. Mini-review protease inhibitor (PI) and Pis from sponge-associated microorganisms. Vietnam J Sci Technol. 2018;56(4):405. doi:10.15625/2525-2518/56/4/10911
   Google Scholar
• Belon CA, Frick DN. Helicase Inhibitors as Specifically Targeted Antiviral Therapy for Hepatitis C. 2009.
   Google Scholar
• Jensen DM. A new era of hepatitis C therapy begins. N Engl J Med. 2011;364(13):1272–1274. doi:10.1056/NEJMe110082921449791
   PubMed Web of Science ®Google Scholar
• Li B, Li L, Peng Z, et al. Harzianoic acids A and B, new natural scaffolds with inhibitory effects against hepatitis C virus. Bioorg Med Chem. 2019;27(3):560–567. doi:10.1016/j.bmc.2018.12.03830606673
   PubMed Web of Science ®Google Scholar
• Lange CM, Sarrazin C, Zeuzem S. specifically targeted anti‐viral therapy for hepatitis C–a new era in therapy. Aliment Pharmacol Ther. 2010;32(1):14–28. doi:10.1111/j.1365-2036.2010.04317.x20374226
   PubMed Web of Science ®Google Scholar
• Feld JJ, Hoofnagle JH. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature. 2005;436(7053):967. doi:10.1038/nature0408216107837
   PubMed Web of Science ®Google Scholar
• Kjellin M, Wesslén T, Löfblad E, Lennerstrand J, Lannergård A. The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort. Ups J Med Sci. 2018;123(1):50–56. doi:10.1080/03009734.2018.144192829536805
   PubMed Web of Science ®Google Scholar
• Chen C, Qiu H, Gong J, et al. (−)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus. Arch Virol. 2012;157(7):1301–1312. doi:10.1007/s00705-012-1304-022491814
   PubMed Web of Science ®Google Scholar
• Gonzalez O, Fontanes V, Raychaudhuri S, et al. The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production. Hepatology. 2009;50(6):1756–1764. doi:10.1002/hep.2323219839005
   PubMed Web of Science ®Google Scholar
• Bachmetov L, Gal‐Tanamy M, Shapira A, et al. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity. J Viral Hepatitis. 2012;19(2):e81–e88. doi:10.1111/j.1365-2893.2011.01507.x
   PubMed Web of Science ®Google Scholar
• Li Y, Yu S, Liu D, Proksch P, Lin W. Inhibitory effects of polyphenols toward HCV from the mangrove plant Excoecaria agallocha L. Bioorg Med Chem Lett. 2012;22(2):1099–1102. doi:10.1016/j.bmcl.2011.11.10922196120
   PubMed Web of Science ®Google Scholar
• Sahuc M-E, Sahli R, Rivière C, et al. Dehydrojuncusol, a natural phenanthrene compound extracted from juncus maritimus is a new inhibitor of hepatitis C virus RNA replication. J Virol. 2019;JVI:02009–02018.
   Google Scholar
• Sepčić K, Kauferstein S, Mebs D, Turk T. Biological activities of aqueous and organic extracts from tropical marine sponges. Mar Drugs. 2010;8(5):1550. doi:10.3390/md805155020559488
   PubMed Web of Science ®Google Scholar
• Shady N, El-Hossary E, Fouad M, Gulder T, Kamel M, Abdelmohsen U. Bioactive natural products of marine sponges from the genus Hyrtios. Molecules. 2017;22(5):781. doi:10.3390/molecules22050781
   PubMed Web of Science ®Google Scholar
• Abdelmohsen UR, Balasubramanian S, Oelschlaeger TA, et al. Potential of marine natural products against drug-resistant fungal, viral, and parasitic infections. Lancet Infect Dis. 2017;17(2):e30–e41. doi:10.1016/S1473-3099(16)30323-127979695
   PubMed Web of Science ®Google Scholar
• Liu M, El-Hossary EM, Oelschlaeger TA, Donia MS, Quinn RJ, Abdelmohsen UR. Potential of marine natural products against drug-resistant bacterial infections. Lancet Infect Dis. 2019.
   Web of Science ®Google Scholar
• Ahmed EF, Rateb ME, Abou El-Kassem LT, Hawas UW. Anti-HCV protease of diketopiperazines produced by the Red Sea sponge-associated fungus Aspergillus versicolor. Appl Biochem Biotechnol. 2017;53(1):101–106.
   Google Scholar
• Na M, Ding Y, Wang B, et al. Anti-infective discorhabdins from a deep-water Alaskan sponge of the genus Latrunculia. Indian J Nat Prod Resour. 2009;73(3):383–387. doi:10.1021/np900281r
   Google Scholar
• Cheung RCF, Wong JH, Pan WL, et al. Antifungal and antiviral products of marine organisms. Appl Microbiol Biotechnol. 2014;98(8):3475–3494. doi:10.1007/s00253-014-5575-024562325
   PubMed Web of Science ®Google Scholar
• Hirano K, Kubota T, Tsuda M, Mikami Y, Kobayashi J. Pyrinodemins BD, potent cytotoxic bis-pyridine alkaloids from marine sponge Amphimedon sp. Chem Pharm Bull. 2000;48(7):974–977. doi:10.1248/cpb.48.97410923825
   PubMed Web of Science ®Google Scholar
• Kubota T, Kamijyo Y, Takahashi-Nakaguchi A, Fromont J, Gonoi T, Kobayashi J. Zamamiphidin A, a new manzamine related alkaloid from an Okinawan marine sponge Amphimedon sp. Org Lett. 2013;15(3):610–612. doi:10.1021/ol303427423343122
   PubMed Web of Science ®Google Scholar
• Sakurada T, Gill MB, Frausto S, et al. Novel N-methylated 8-oxoisoguanines from Pacific sponges with diverse neuroactivities. Eur J Med Chem. 2010;53(16):6089–6099. doi:10.1021/jm100490m
   Google Scholar
• Ovenden SP, Capon RJ, Lacey E, Gill JH, Friedel T, Wadsworth D. Amphilactams A− D: novel nematocides from Southern Australian Marine sponges of the Genus Amphimedon. JOC. 1999;64(4):1140–1144. doi:10.1021/jo981377e
   Google Scholar
• Emura C, Higuchi R, Miyamoto T, Van Soest RW. Amphimelibiosides A− F, six new ceramide dihexosides isolated from a Japanese Marine Sponge Amphimedon sp. JOC. 2005;70(8):3031–3038. doi:10.1021/jo048635u
   Google Scholar
• Nemoto T, Yoshino G, Ojika M, Sakagami Y. Amphimic acids and related long-chain fatty acids as DNA topoisomerase I inhibitors from an Australian sponge, Amphimedon sp.: isolation, structure, synthesis, and biological evaluation. Tetrahedron. 1997;53(49):16699–16710. doi:10.1016/S0040-4020(97)10099-0
   Web of Science ®Google Scholar
• Shady NH, Fouad MA, Salah Kamel M, Schirmeister T, Abdelmohsen UR. Natural product repertoire of the Genus Amphimedon. Mar Drugs. 2018;17(1):19. doi:10.3390/md17010019
   PubMed Web of Science ®Google Scholar
• O’Rourke A. Bioprospecting of Red Sea Sponges for Novel Antiviral Pharmacophores. 2015.
   Google Scholar
• Costa FG, BRdS N, Gonçalves RL, et al. Alkaloids as Inhibitors of malate synthase from span class=“named-content genus-species” id=“named-content-1”paracoccidioides span spp.: receptor-ligand interaction-based virtual screening and molecular docking studies, antifungal activity, and the adhesion process. Antimicrob Agents Chemother. 2015;59(9):5581–5594. doi:10.1128/AAC.04711-1426124176
   PubMed Web of Science ®Google Scholar
• Montefiori DC. Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays. Curr Protoc Immunol. 2004;64(1):12.11.11–12.11. 17. doi:10.1002/0471142735.im1211s64
   Google Scholar
• Inc. CCG. Molecular Operating Environment (MOE), 2012.10. 1010 Sherbrooke St.west, Suite #910. Montr. QC, Canada, H3A 2R7; 2012.
   Google Scholar
• Nasr T, Bondock S, Eid S. Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety. Eur J Med Chem. 2014;84:491–504. doi:10.1016/j.ejmech.2014.07.05225050881
   PubMed Web of Science ®Google Scholar
• Avilala J, Golla N. Antibacterial and antiviral properties of silver nanoparticles synthesized by marine actinomycetes. Int J Pharm Sci & Res. 2019;10(3):1223–1228.
   Web of Science ®Google Scholar
• Tsuda M, Inaba K, Kawasaki N, Honma K, Kobayashi J. Chiral resolution of (±)-keramaphidin B and isolation of manzamine L, a new β-carboline alkaloid from a sponge Amphimedon sp. Tetrahedron. 1996;52(7):2319–2324. doi:10.1016/0040-4020(95)01057-2
   Web of Science ®Google Scholar
• Tsuda M, Watanabe D, Kobayashi J. Ma’eganedin A, a new manzamine alkaloid from Amphimedon sponge. Tetrahedron Lett. 1998;39(10):1207–1210. doi:10.1016/S0040-4039(97)10842-5
   Web of Science ®Google Scholar
• Kobayashi J, Watanabe D, Kawasaki N, Tsuda M. Nakadomarin A, a novel hexacyclic manzamine-related alkaloid from Amphimedon sponge. JOC. 1997;62(26):9236–9239. doi:10.1021/jo9715377
   Google Scholar
• Jeong S-J, Inagaki M, Higuchi R, et al. 1, 3-Dimethylisoguaninium, an antiangiogenic purine analog from the sponge amphimedon paraviridis. Chem Pharm Bull. 2003;51(6):731–733. doi:10.1248/cpb.51.73112808256
   PubMed Web of Science ®Google Scholar
• Tsukamoto S, Takahashi M, Matsunaga S, Fusetani N, Van Soest RW. Hachijodines A− G: seven new cytotoxic 3-alkylpyridine alkaloids from two marine sponges of the Genera Xestospongia and Amphimedon. J Nat Prod. 2000;63(5):682–684. doi:10.1021/np990576610843588
   PubMed Web of Science ®Google Scholar
• Nishi T, Kubota T, Fromont J, Sasaki T, Kobayashi J. Nakinadines B–F: new pyridine alkaloids with a β-amino acid moiety from sponge Amphimedon sp. Tetrahedron. 2008;64(14):3127–3132. doi:10.1016/j.tet.2008.01.111
   Web of Science ®Google Scholar
• Tsuda M, Kawasaki N, Kobayashi J. Ircinols A and B, first antipodes of manzamine-related alkaloids from an Okinawan marine sponge. Tetrahedron. 1994;50(27):7957–7960. doi:10.1016/S0040-4020(01)85280-7
   Web of Science ®Google Scholar
• Kobayashi J, Tsuda M, Kawasaki N, Sasaki T, Mikami Y. 6-Hydroxymanzamine A and 3, 4-dihydromanzamine A, new alkaloids from the Okinawan marine sponge Amphimedon Sp. J Nat Prod. 1994;57(12):1737–1740. doi:10.1021/np50114a0217714542
   PubMed Web of Science ®Google Scholar
• Watanabe D, Tsuda M, Kobayashi J. Three new manzamine congeners from amphimedon sponge. J Nat Prod. 1998;61(5):689–692. doi:10.1021/np970564p9599281
   PubMed Web of Science ®Google Scholar
• Carballeira NM, Restituyo J. Identification of the new 11, 15-icosadienoic acid and related acids in the sponge Amphimedon complanata. J Nat Prod. 1991;54(1):315–317. doi:10.1021/np50073a0432045822
   PubMed Web of Science ®Google Scholar
• Carballeira NM, Colón R, Emiliano A. Identification of 2-methoxyhexadecanoic acid in Amphimedon compressa. J Nat Prod. 1998;61(5):675–676. doi:10.1021/np970578v9599277
   PubMed Web of Science ®Google Scholar
• Carballeira NM, Negrón V, Reyes ED. Novel monounsaturated fatty acids from the sponges Amphimedon compressa and Mycale laevis. J Nat Prod. 1992;55(3):333–339. doi:10.1021/np50081a009
   Web of Science ®Google Scholar
• Takekawa Y, Matsunaga S, van Soest RW, Fusetani N. Amphimedosides, 3-alkylpyridine glycosides from a marine sponge Amphimedon sp. J Nat Prod. 2006;69(10):1503–1505. doi:10.1021/np060122q17067172
   PubMed Web of Science ®Google Scholar
• Kobayashi J, Tsuda M, Kawasaki N, Matsumoto K, Adachi T. Keramaphidin B, a novel pentacyclic alkaloid from a marine sponge Amphimedon sp.: a plausible biogenetic precursor of manzamine alkaloids. Tetrahedron Lett. 1994;35(25):4383–4386. doi:10.1016/S0040-4039(00)73362-4
   Web of Science ®Google Scholar
• Schmitz FJ, Agarwal SK, Gunasekera SP, Schmidt PG, Shoolery JN. Amphimedine, new aromatic alkaloid from a pacific sponge, Amphimedon sp. carbon connectivity determination from natural abundance carbon-13-carbon-13 coupling constants. J Am Chem Soc. 1983;105(14):4835–4836. doi:10.1021/ja00352a052
   Web of Science ®Google Scholar
• Beran RK, Serebrov V, Pyle AM. The serine protease domain of hepatitis C viral NS3 activates RNA helicase activity by promoting the binding of RNA substrate. J Biol Chem. 2007;282(48):34913–34920. doi:10.1074/jbc.M70716520017921146
   PubMed Web of Science ®Google Scholar
• Beran RK, Pyle AM. Hepatitis C viral NS3-4A protease activity is enhanced by the NS3 helicase. J Biol Chem. 2008;283(44):29929–29937. doi:10.1074/jbc.M80406520018723512
   PubMed Web of Science ®Google Scholar
• Morgenstern KA, Landro JA, Hsiao K, et al. Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected COS cells. J Virol. 1997;71(5):3767–3775. doi:10.1128/JVI.71.5.3767-3775.19979094652
   PubMed Web of Science ®Google Scholar
• Lipinski CA. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2004;1(4):337–341. doi:10.1016/j.ddtec.2004.11.00724981612
   PubMedGoogle Scholar
• Ebejer J-P, Charlton MH, Finn PW. Are the physicochemical properties of antibacterial compounds really different from other drugs? J Cheminform. 2016;8(1):30. doi:10.1186/s13321-016-0143-527274770
   PubMedGoogle Scholar